| First Author | Lownik JC | Year | 2019 |
| Journal | J Immunol | Volume | 202 |
| Issue | 3 | Pages | 664-674 |
| PubMed ID | 30610163 | Mgi Jnum | J:270110 |
| Mgi Id | MGI:6274910 | Doi | 10.4049/jimmunol.1801207 |
| Citation | Lownik JC, et al. (2019) B Cell ADAM10 Controls Murine Lupus Progression through Regulation of the ICOS:ICOS Ligand Axis. J Immunol 202(3):664-674 |
| abstractText | The role of ICOS and its ligand (ICOSL) have both been shown to be essential for proper humoral responses as well as autoimmune Ab development in mouse models of lupus. In this paper, we report a specific role for the metalloprotease ADAM10 on B cells in regulating both ICOSL and ICOS in a mouse model of increased humoral immunity using B6(mir146a-/-) mice and a model of lymphoproliferative disease using the well-characterized lpr model. B6(lpr) mice lacking ADAM10 on B cells (A10B(lpr)) have decreased nodal proliferation and T cell accumulation compared with control B6(lpr) mice. Additionally, A10B(lpr) mice have a drastic reduction in autoimmune anti-dsDNA Ab production. In line with this, we found a significant reduction in follicular helper T cells and germinal center B cells in these mice. We also show that lymphoproliferation in this model is closely tied to elevated ICOS levels and decreased ICOSL levels. Overall, our data not only show a role of B cell ADAM10 in control autoimmunity but also increase our understanding of the regulation of ICOS and ICOSL in the context of autoimmunity. |
